Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise

PHASE3TerminatedINTERVENTIONAL

Enrollment

321

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

ObesityDiabetes Mellitus Type 2

Interventions

DRUG

Rimonabant

Tablet, oral administration

DRUG

placebo (for Rimonabant)

Tablet, oral administration

OTHER

Diet and exercise

Target daily caloric intake: Ideal body weight × 25 kcal

Trial Locations (1)

Sanofi-Aventis Administrative Office, Tokyo